FIELD: medicine; dentistry.
SUBSTANCE: invention implies production of therapeutic agent and treatment method for periodontium and pulp diseases as well as to production of periodontal tissue regenerative transplant neurotrophic agents as active substance.
EFFECT: invention provides more effective endodontic therapy.
23 cl, 8 ex, 43 dwg
| Title |
Year |
Author |
Number |
| ISOLATED DNA FRAGMENT, A METHOD OF PREPARING A RECOMBINANT PROTEIN EXHIBITING NEUROTROPIC ACTIVITY, PROTEIN NT-3 AND A PHARMACEUTICAL COMPOSITION |
1990 |
- Andres Khon
- Joakhim Ljajbrok
- Karen Bailej
- Ives-Alan Bard
- Khans Toenen
- Piter Mejsonpir
- Mark Fert
- Ronal'D Lindsej
- Dzhorzh Jankopulos
|
RU2128226C1 |
| METHOD FOR CARDIO-GENERATIVE POTENTIAL DETERMINATION IN MAMMAL CELLS |
2010 |
- Gordon-Beresford, Roland
- Gossin, Vintsian
- Omsi, Kristian
- Terzik, Andre
- Befar, Atta
|
RU2624498C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF NEUROLOGIC DISEASES |
2007 |
- Dudkin Sergej Marovich
- Kurochkin Sergej Nikolaevich
- Kolobkov Sergej Leonidovich
- Volchek Igor' Anatol'Evich
- Lukachevskij Pavel L'Vovich
|
RU2335296C1 |
| DNA-FRAGMENT ENCODING BRAIN NEUROTROPIC FACTOR (BDNF), BDNF PROTEIN AND METHOD OF ITS PREPARING |
1990 |
- Kehrolin Khajman
- Ral'F Alderson
- Dzhorzh Jankopulos
- Ives-Alan Bard
- Khans Toenen
- Andres Khon
- Fridrikh Lottshpajkh
- Ronal'D Lindsej
- Magdalena Khofer
- Joakhim Ljajbrok
- Dehvid Ehdgar
- Bastian Khengerer
- Dan Lindkhol'M
- Frantsisko Tsafra
|
RU2131926C1 |
| GENE-THERAPEUTIC DNA-VECTOR BASED ON THE GENE-THERAPEUTIC DNA-VECTOR VTVAF17, CARRYING THE TARGET GENE SELECTED FROM A GROUP OF GENES BDNF, VEGFA, BFGF, NGF, GDNF, NT3, CNTF, IGF1, TO INCREASE EXPRESSION LEVEL OF SAID TARGET GENES, METHOD FOR PRODUCTION AND USE THEREOF, A STRAIN ESCHERICHIA COLI SCS110-AF/VTVAF17-BDNF, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-VEGFA, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-BFGF, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-NGF, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-GDNF, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-NT3, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-CNTF, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-IGF1, CARRYING A GENE-THERAPEUTIC DNA VECTOR, METHOD FOR PRODUCTION THEREOF, A METHOD FOR INDUSTRIAL PRODUCTION OF A GENE-THERAPEUTIC DNA VECTOR |
2018 |
|
RU2732479C2 |
| BDNF-BASED (BRAIN-DERIVED NEUROTROPHIC FACTOR) OPHTHALMIC PREPARATIONS AND USING THEM |
2010 |
- Domenichi Luchano
- Dzhovannini Luka
- Sanso Marko
|
RU2564920C2 |
| CELL COMPOSITIONS AND METHODS OF THEIR APPLICATION FOR TREATING CARDIAC TISSUE |
2009 |
- Terzhik Andre
- Bekhfar Atta
|
RU2519762C2 |
| TREATMENT OF BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO BDNF |
2013 |
- Faghihi Mohammad Ali
- Coito Carlos
|
RU2661104C2 |
| USING MESENCHYMAL AND NEURONAL MARKER EXPRESSING STEM CELLS AND THEIR COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASES (VERSIONS) |
2017 |
- Kerkis, Irina
- Valverde Ventseslau, Kristian
|
RU2742828C2 |
| ARTIFICIAL PEPTIDE FOR CRANIOCEREBRAL INJURY TREATMENT |
2023 |
- Shamova Olga Valerevna
- Klimov Nikolaj Anatolevich
- Zharkova Mariya Sergeevna
- Serebryanaya Natalya Borisovna
- Shanin Sergej Nikolaevich
- Filatenkova Tatyana Aleksandrovna
- Fomicheva Elena Evgenevna
- Komlev Aleksej Sergeevich
- Umnyakova Ekaterina Sergeevna
- Orlov Dmitrij Sergeevich
|
RU2816919C1 |
